Skip to content

A study to assess the role of giving Pressurised Oxygen in patients of Pancreatitis

Role of Hyperbaric Oxygen Therapy in Severe Acute Pancreatitis: A pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027315
Enrollment
20
Registered
2020-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K859- Acute pancreatitis, unspecified

Interventions

Intervention1: Hyperbaric Oxygen Therapy: Hyperbaric exposure at 2.5 ATA for 90 minutes in HBO chamber (Monoplace Hyperbaric System, Sigma 36 Elite, Chamber serial number 1209-36) Control Intervention

Sponsors

Department of Anaesthesiology and Critical Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults (aged 18-70years) of either sex ,admitted in ICU and diagnosed as a case of severe acute pancreatitis, defined as persistent single or multiple organ failure for >48hr based on 2012 revision of Atlanta classification.

Exclusion criteria

Exclusion criteria: 1. Refusal for consent 2. Pregnant patients 3. Any contraindication for Hyperbaric oxygen therapy such as cavitary or current tuberculosis, heart failure, pulmonary edema, acute purulent sinusitis, severe glaucoma, hypercapnic respiratory insufficiency with PCO2 > 60mm Hg, previous rupture of inner earâ??s membrane, sinus bradycardia, inflammation of upper respiratory tract, epilepsy, claustrophobia 4. Patient on mechanical ventilation support

Design outcomes

Primary

MeasureTime frame
Primary outcome is to assess the need for mechanical ventilation in patients of Severe Acute Pancreatitis receiving HBO therapyTimepoint: Till patient discharge from ICU or death

Secondary

MeasureTime frame
Mortality, change in CRP values, Procalcitonin values, duration of ICU stayTimepoint: Till patient discharge from ICU or death

Countries

India

Contacts

Public ContactDr Samiksha Parashar

Dr.Ram Manohar Lohia Institute of Medical Sciences

samikshaparashar@gmail.com7042345280

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026